Med
Scope & Guideline
Pioneering Interdisciplinary Insights in Medicine.
Introduction
Aims and Scopes
- Precision Medicine and Targeted Therapies:
The journal emphasizes the development and application of precision medicine and targeted therapies, particularly in oncology and chronic diseases, highlighting individualized treatment strategies based on genetic and molecular profiling. - Innovations in Drug Development:
Research related to novel drug discovery, including the use of artificial intelligence (AI) in accelerating drug development and clinical trials, is a core focus, aiming to enhance therapeutic efficacy and safety. - Immunotherapy and Cancer Treatment:
A significant portion of the published works revolves around immunotherapy, including checkpoint inhibitors and CAR T-cell therapies, reflecting the journal's commitment to exploring advanced cancer treatments. - Global Health and Epidemiology:
Publications frequently address global health disparities, epidemiological studies, and the socio-economic factors influencing health outcomes, showcasing the journal's dedication to comprehensive health research. - Translational Medicine and Clinical Trials:
The journal aims to bridge the gap between laboratory research and clinical application by publishing clinical trials and translational studies that offer insights into new therapeutic approaches. - Public Health and Infectious Diseases:
With a strong focus on public health, particularly in light of the COVID-19 pandemic, the journal addresses infectious disease management, vaccine development, and health policy implications.
Trending and Emerging
- Artificial Intelligence in Healthcare:
The integration of AI in healthcare research is rapidly increasing, focusing on its potential to revolutionize diagnostics, treatment planning, and patient monitoring, thereby enhancing clinical outcomes. - Mental Health and Wellbeing:
Emerging studies on mental health, particularly in the context of chronic illness and the impact of pandemics, indicate a growing recognition of the importance of psychological factors in overall health. - Long COVID and Post-Acute Sequelae:
Research on long COVID and its associated health implications is trending, as healthcare systems seek to understand and address the long-term effects of COVID-19 on diverse populations. - Regenerative Medicine and Stem Cell Therapy:
There is an increasing focus on regenerative medicine, particularly stem cell therapies, highlighting their potential to treat various conditions previously deemed untreatable. - Health Equity and Social Determinants of Health:
A growing body of work is dedicated to examining health equity and the social determinants of health, reflecting a commitment to addressing disparities in healthcare access and outcomes. - Vaccines and Immunization Strategies:
The ongoing research into vaccines, especially in response to the COVID-19 pandemic, has spurred a renewed interest in immunization strategies and their role in public health.
Declining or Waning
- Traditional Pharmacotherapy:
There is a noticeable decrease in research focused solely on traditional pharmacotherapy approaches, as the emphasis shifts towards personalized and combination therapies that integrate new technologies. - Basic Science Without Clinical Application:
Papers that focus solely on basic science without a clear clinical application have diminished, indicating a trend towards more translational research that directly impacts patient care. - Non-Invasive Diagnostic Techniques:
While still relevant, the frequency of publications on non-invasive diagnostic techniques has decreased, as the field moves towards more integrated and comprehensive approaches to patient assessment. - Conventional Imaging Modalities:
The use of conventional imaging modalities as standalone diagnostic tools is waning, with more emphasis now placed on advanced imaging techniques and their integration with molecular diagnostics.
Similar Journals
Journal of the Chinese Medical Association
Elevating Standards in Medical Research and PracticeJournal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.
LANCET ONCOLOGY
Empowering the oncology community with cutting-edge knowledge.The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.
Journal of Hepatocellular Carcinoma
Transforming research into impactful liver cancer therapies.The Journal of Hepatocellular Carcinoma is a pivotal open-access publication dedicated to advancing the field of hepatocellular carcinoma research. Published by DOVE MEDICAL PRESS LTD since 2014, this journal seeks to disseminate high-quality articles that explore innovative treatments, clinical trials, and emerging research in the context of liver cancer. With its ISSN: N/A and E-ISSN: 2253-5969, the journal is optimized for a global audience, ensuring accessibility to a broad spectrum of researchers, healthcare professionals, and students engaged in oncology and hepatology. While its Scopus ranking places it in the lower quartiles of the respective fields, the journal continues to strive for growth and visibility in a rapidly evolving landscape. The Journal of Hepatocellular Carcinoma is an essential resource for anyone seeking to enhance their understanding of liver diseases and contribute to the fight against hepatocellular carcinoma.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan
Connecting researchers and practitioners for impactful healthcare.Welcome to the JCPSP-Journal of the College of Physicians and Surgeons Pakistan, a pivotal platform for advancing knowledge in the field of medicine. Published by the College of Physicians and Surgeons Pakistan, this distinguished journal, with the ISSN 1022-386X and E-ISSN 1681-7168, has been disseminating critical research and clinical insights since 1996. With a focus on various realms of general medicine and holding a current Scopus rank of #291 out of 636, the JCPSP is classified in the Q3 quartile for miscellaneous medicine, indicating its growing influence and expertise. The journal aims to foster scholarly communication and collaboration among healthcare professionals, researchers, and students in Pakistan and beyond, enhancing clinical practice and medical education. Although it does not currently offer Open Access, its curated content and comprehensive research articles are essential for those engaged in the medical sciences. Join us in exploring the latest findings and contributions impacting the healthcare landscape in Pakistan and worldwide.
Journal of Translational Medicine
Transforming Research into Real-World Impact.Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.
Frontiers in Medicine
Connecting minds to transform healthcare practices.Frontiers in Medicine, published by FRONTIERS MEDIA SA, is a distinguished open-access journal that has been at the forefront of medical research since its inception in 2014. With an impressive 2023 Q1 ranking in the field of miscellaneous medicine and a notable Scopus rank of #93 out of 636—placing it in the 85th percentile in the general medicine category—this journal serves as a pivotal resource for academics and practitioners. Hailing from Switzerland, Frontiers in Medicine aims to publish high-quality research that addresses the most pressing issues in the medical field, fostering innovation and collaboration among researchers worldwide. By facilitating open access to comprehensive, peer-reviewed articles, the journal enhances the dissemination of knowledge and encourages interdisciplinary dialogues essential for medical advancement. Whether you're a researcher, a clinician, or a student, this journal is an invaluable tool for staying abreast of the latest developments in medicine.
Annals of African Medicine
Innovating solutions for African medical practices.Annals of African Medicine is a distinguished academic journal dedicated to the exploration and dissemination of significant research within the field of medicine, particularly focused on the African context. Published by Wolters Kluwer Medknow Publications in India, this journal has been a vital platform for scholars since its inception in 2005, with a commitment to improving healthcare practices and outcomes across the continent. While it currently holds a Q4 ranking in the broader field of Medicine (miscellaneous) according to the 2023 category quartiles, it has the potential to foster valuable insights that address unique medical challenges facing African populations. The journal's ISSN is 1596-3519, and it is also available under the E-ISSN 0975-5764. Accessible to a diverse audience of researchers, professionals, and students, the Annals of African Medicine not only serves as an academic archive but also encourages discussions and initiatives aimed at advancing health-related knowledge and practices in Africa.
NEW ENGLAND JOURNAL OF MEDICINE
Setting the Standard for Medical ExcellenceThe New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.
CHINESE MEDICAL JOURNAL
Bridging tradition and innovation in medical research.CHINESE MEDICAL JOURNAL, published by Lippincott Williams & Wilkins, is a distinguished platform within the field of medicine, providing a vital forum for the dissemination of innovative research and clinical findings since its inception in 1946. With its open access model established in 2000, the journal ensures that critical medical advancements and insights are accessible to a global audience, fostering collaboration and continuous learning among researchers, healthcare professionals, and students alike. The journal’s impressive Q1 ranking in Medicine (miscellaneous), alongside its remarkable Scopus rank of #40 out of 636 in General Medicine, underscores its influential presence in the medical community, promoting high-quality research that advances health outcomes. As it converges historical and contemporary research, the CHINESE MEDICAL JOURNAL plays an essential role in bridging academic inquiry with practical medical application, emphasizing its commitment to improving global healthcare through rigorous scholarship and excellence.
Cancer Biology & Medicine
Bridging Knowledge Gaps in OncologyCancer Biology & Medicine is a distinguished Open Access journal published by the China Anti-Cancer Association, dedicated to advancing research and understanding in the fields of Cancer Research and Oncology. Since its inception in 2012, the journal has provided a vital platform for the dissemination of high-quality research, evidenced by its impressive ranking within the Q1 and Q2 categories of oncology and cancer research as of 2023. With a significant impact factor and a Scopus ranking of #64 in Medicine/Oncology and #55 in Biochemistry, Genetics, and Molecular Biology, it plays a crucial role in shaping the future of cancer biology. By offering open access to its content, the journal ensures that pivotal research findings are readily available to researchers, professionals, and students globally, thereby fostering collaboration and innovation in cancer research. Situated in Tianjin, China, this journal is poised at the frontier of oncology research, making a significant impact through its rigorous peer-reviewed articles that address critical challenges in the field.